Artificial Kidney Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 2.30 Billion |
| Market Size (2029) | USD 4.40 Billion |
| CAGR (2024 - 2029) | 13.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Artificial Kidney Market Analysis
The Artificial Kidney Market size is estimated at USD 2.30 billion in 2024, and is expected to reach USD 4.40 billion by 2029, growing at a CAGR of 13.90% during the forecast period (2024-2029).
The market is expected to grow owing to the surging burden of chronic kidney diseases, the scarcity of donors, and technological advances in artificial kidneys. In addition, supportive government legislation to promote the uptake of artificial kidneys is anticipated to boost market growth during the forecast period.
The growing burden of chronic diseases such as chronic kidney diseases, end-stage renal diseases, and kidney failure may drive the demand for artificial kidneys, as artificial kidneys are designed to work like the natural kidney, filtering the blood and maintaining the body's fluid balance. For instance, according to an article published by the Lancet Global Health in March 2024, chronic kidney disease emerged as a significant global issue and is estimated to affect around 10% of the global population.
In addition, the increased burden of chronic kidney conditions across developed countries is projected to fuel the demand for artificial kidneys for healthy living, which is further anticipated to boost market growth during the forecast period. For instance, according to May 2024 updated data from the Centers for Disease Control and Prevention (CDC), chronic kidney disease (CKD) is a significant burden in the United States, and around 35.5 million people, or 14% of the United States population have CKD in the country. Thus, such a remarkable burden of kidney disease is likely to fuel the demand for advanced treatment options like artificial kidneys.
The scarcity of kidney donors is expected to increase the demand for artificial kidneys for effective health management. For instance, according to the Kidney Foundation Funds Data updated in June 2024, more than 93,000 Americans were on the kidney transplant waiting list. Yet, only 27,332 among them were able to receive a kidney transplant. This indicates a huge scarcity of donors for kidney transplants, and thus, it is expected to boost the artificial kidney market during the forecast period.
Moreover, according to an article published by the Journal of Transplantation in March 2024, the scarcity of compatible living donors fuels the kidney transplant shortage and creates extended patient waiting times. Thus, the scarcity associated with kidney transplants and increased waiting times is anticipated to augment the development of artificial kidney products, which, in turn, is projected to boost market growth during the forecast period.
Thus, the above-mentioned factors, such as the surging burden of chronic kidney diseases, the scarcity of donors, and technological advances in artificial kidneys, are projected to accelerate industry uptake during the forecast period. However, the less penetration of artificial kidneys in developing and low- and middle-income countries and the higher cost of these kidneys are anticipated to hamper market growth during the forecast period.
Artificial Kidney Market Trends
The Wearable Artificial Kidney Segment is Expected to Hold a Significant Share in Market During the Forecast Period
Wearable artificial kidneys are a portable medical technology that allows patients to benefit from dialysis at home while going about their daily activities. This gadget improves the lives of patients with end-stage renal disease by eliminating hospital stays and enhancing physiological aspects by lowering hypertension. It reduces sodium retention and the risk of stroke and vascular disease, and it is less expensive than alternative medications for renal failure patients.
Factors such as the rising prevalence of kidney diseases, the growing uptake of wearable artificial kidneys, and strategic initiatives by market players are anticipated to boost segment growth during the forecast period.
Wearable/portable kidneys improve dialysis by allowing for home dialysis and improving frequency and autonomy, which leads to an increase in the demand for wearable kidneys over the implantable kidney. Home dialysis has advantages over in-center hemodialysis and has the potential to save the healthcare system money. There are several portable home hemodialysis systems available, including the NxStage System One (NxStage Medical Inc.), the 2008K home (Fresenius Medical Care), and the SC+ hemodialysis system (Quanta).
In addition, the profound role of artificial kidneys in dialysis and several other benefits associated with wearable artificial kidneys are further anticipated to propel segment expansion during the forecast period. For instance, according to an article published by the World Journal of Transplantation in March 2024, wearable artificial kidneys are significantly useful in patients with kidney failure. In addition, as per the same source, the wearable artificial kidney was well tolerated in patients and is mainly used for fluid homeostasis. Thus, such benefits associated with these systems are anticipated to augment their adoption and are projected to boost segment growth during the forecast period.
Additionally, the growing focus of market players on developing wearable artificial kidneys and their anticipated launch in the market is expected to boost the market growth. For instance, in February 2023, NextKidney raised EUR 11.9 million (USD 14.82 million) in a Series B round of funding to develop a portable hemodialysis device for patients. Thus, such efforts undertaken by the industry participants are projected to foster segment expansion, which is anticipated to boost market growth during the forecast period.
Thus, all aforementioned factors, such as the growing burden of kidney diseases and regulatory approval and funding activities, are expected to boost the segment's growth during the forecast period.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is projected to have a significant market share in the artificial kidney market during the forecast period. This is due to factors such as the increasing prevalence of chronic kidney diseases and kidney cancers, as well as the presence of well-established healthcare infrastructure and high health spending. Additionally, the significant presence of market participants in the region and various strategic initiatives undertaken by industry participants are further expected to promote regional market growth. The growing burden of kidney diseases, which lead to kidney damage or failure, is likely to increase the demand for artificial kidneys. For instance, according to an article published by the Canadian Journal of Kidney Health and Disease in February 2023, in Canada, chronic kidney disease (CKD) is a significant health problem, and around 4 million Canadians are living with the condition. In addition, according to 2024 updated data from the American Cancer Society, around 81,610 Americans are projected to be diagnosed with kidney cancer in 2024. Thus, the significant burden of chronic kidney disease and kidney cancer is projected to augment the demand for artificial kidneys to restore normal kidney functions, which, in turn, is projected to boost market growth during the forecast period.
In addition, the increased funding activities for the development of artificial kidney products are further projected to accelerate regional market growth. For instance, in August 2023, Dr. William Chang received a prize of USD 9.2 million to bolster his research on bioartificial kidneys.
Moreover, in August 2022, the American Society of Nephrology (ASN) and the United States Department of Health and Human Services (HHS) announced a new prize competition from KidneyX and that KidneyX launched a new artificial kidney prize with USD 10.5 million in funding. Thus, such growing funding activities for artificial kidneys in the region are anticipated to foster growth over the coming years.
Thus, all aforementioned factors, such as the growing burden of chronic kidney diseases and the growing focus on the development of artificial kidneys, are expected to boost the market during the forecast period.
Artificial Kidney Industry Overview
The artificial kidney market is moderately competitive due to the presence of many major market players. Market players implement organic strategies and product launches, whereas companies with inorganic growth strategies, such as acquisitions, partnerships, and collaborations, take precedence. Some of the key market players are B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd, NIPRO Medical Corporation, Nikkiso Co. Ltd, and Fresenius Medical Care AG & Co. KGaA.
Artificial Kidney Market Leaders
-
B. Braun Melsungen AG
-
Asahi Kasei Medical Co. Ltd.,
-
NIPRO Medical Corporation
-
Nikkiso Co., Ltd
-
Fresenius Medical Care AG & Co. KGaA
*Disclaimer: Major Players sorted in no particular order
Artificial Kidney Market News
- May 2023: A kidney doctor in Southern California and engineering researchers at the University of Arkansas collaborated to develop a waterless artificial kidney. The collaboration holds a potential promise to revolutionize kidney disease treatment.
- April 2023: Medtronic PLC and DaVita Inc. created a new company called Mozarc Medical, which is dedicated to changing renal health and developing patient-centered technological solutions.
Artificial Kidney Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Incidence of Chronic Kidney Diseases
- 4.2.2 Scarcity of Donor Organs
- 4.2.3 Technological Advancements in the Artificial Kidney
-
4.3 Market Restraints
- 4.3.1 Expensive Procedures and Products
- 4.3.2 Risks Associated With Artificial Kidney
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Device Type
- 5.1.1 Wearable Artificial Kidney
- 5.1.2 Implantable Artificial Kidney
-
5.2 By End User
- 5.2.1 Hospitals
- 5.2.2 Specialty Clinics
- 5.2.3 Ambulatory Surgical Centers
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 B. Braun Medical Inc.
- 6.1.2 Asahi Kasei Medical Co. Ltd
- 6.1.3 DaVita Inc.
- 6.1.4 Nipro Medical Corporation
- 6.1.5 Nikkiso Co. Ltd
- 6.1.6 Fresenius Medical Care AG
- 6.1.7 Baxter
- 6.1.8 Medtronic
- 6.1.9 SB-KAWASUMI LABORATORIES INC.
- 6.1.10 Nanodialysis
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityArtificial Kidney Industry Segmentation
As per the scope of the report, the artificial kidney is a device known as a haemodialyzer that filters the blood of a person suffering from kidney disease. It helps to minimize chronic renal disease and improve patients' quality of life. An artificial kidney comprises silicon nano filters that remove water, salts, toxins, and other tiny molecules.
The artificial kidney market is segmented by device type and end user. The market is segmented by device type, such as wearable artificial kidney or implantable artificial kidney. By end user, the market is segmented as hospitals, specialty clinics, and ambulatory surgical centers. The report also covers the market sizes and forecasts for the artificial kidney market in major countries across different regions. For each segment, the market size is provided in terms of value (USD).
| By Device Type | Wearable Artificial Kidney | |
| Implantable Artificial Kidney | ||
| By End User | Hospitals | |
| Specialty Clinics | ||
| Ambulatory Surgical Centers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Artificial Kidney Market Research FAQs
How big is the Artificial Kidney Market?
The Artificial Kidney Market size is expected to reach USD 2.30 billion in 2024 and grow at a CAGR of 13.90% to reach USD 4.40 billion by 2029.
What is the current Artificial Kidney Market size?
In 2024, the Artificial Kidney Market size is expected to reach USD 2.30 billion.
Who are the key players in Artificial Kidney Market?
B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd.,, NIPRO Medical Corporation, Nikkiso Co., Ltd and Fresenius Medical Care AG & Co. KGaA are the major companies operating in the Artificial Kidney Market.
Which is the fastest growing region in Artificial Kidney Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Artificial Kidney Market?
In 2024, the North America accounts for the largest market share in Artificial Kidney Market.
What years does this Artificial Kidney Market cover, and what was the market size in 2023?
In 2023, the Artificial Kidney Market size was estimated at USD 1.98 billion. The report covers the Artificial Kidney Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Artificial Kidney Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Artificial Kidney Industry Report
Statistics for the 2024 Artificial Kidney market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Artificial Kidney analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
